Status:
UNKNOWN
Regimen Switch After Intensive Insulin Therapy
Lead Sponsor:
Shanghai Zhongshan Hospital
Conditions:
Insulin
Eligibility:
All Genders
18+ years
Brief Summary
Insulin intensive therapy have traditionally been considered a sequential therapy in type 2 diabetes last choice, a number of guidelines and consensus recommendations insulin intensive therapy can be ...
Detailed Description
Selecting initial insulin intensive therapy during the period of hospitalization in patients with type 2 diabetes, collect the basic information and biochemical information collection, including gende...
Eligibility Criteria
Inclusion
- Patients with type 2 diabetes;
- Patients who started intensive insulin therapy during hospitalization
- Age ≥18 years old
Exclusion
- Type 1 diabetes, special type diabetes
- Acute complications of diabetes (diabetic ketoacidosis, hyperglycemia and hyperosmolarity)
- Severe infection
- pregnancy or planned pregnancy
- Participating in other clinical studies or trials
Key Trial Info
Start Date :
April 15 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 31 2024
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT04833413
Start Date
April 15 2021
End Date
May 31 2024
Last Update
June 7 2023
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Zhongshan hospital
Shanghai, Shanghai Municipality, China, 200032
2
Department of Endocrinoogy, Zhongshan Hospital Fudan University
Shanghai, China